Advertisement
KPOP NEWS

ENHYPEN Adds More Singapore Dates to Extend Asian World Tour

ENHYPEN is adding another show in Singapore for their ongoing world tour, WALK THE LINE IN ASIA. The new concert date is set for October 5 at the Singapore Indoor Stadium, following the initial show on October 4. This means fans, known as ENGENEs, in Singapore will have two chances to catch the group live.

This Asian leg of the tour kicked off last October at Goyang Sports Complex Main Stadium in South Korea. Since then, ENHYPEN has been blazing through venues at an impressive pace, hitting major milestones. In Japan, they wrapped up a dome tour touching three cities faster than any K-pop boy group managed within four years of debut. That’s a quick rise by any standard.

Advertisement

Earlier this year, the group sold out the Bulacan Sports Stadium in the Philippines twice, with shows in both March and June. They also brought in a massive crowd of over 50,000 fans at Thailand’s biggest venue, Rajamangala National Stadium. The tour isn’t over yet—ENHYPEN will continue performing at stadiums in Japan and has plans to visit 10 cities across the U.S. and Europe throughout August and September.

Alongside their busy touring schedule, they’re preparing to release their fourth Japanese single, "宵 -YOI-," on July 29. The single has three tracks that explore themes of desire and instinct toward someone important. Before the full release, fans can look forward to a pre-release of the title track "Shine On Me" on July 4. It’s a J-pop ballad telling a heartfelt story about a tired narrator finding comfort and hope when someone special appears.

🔥TRENDING
BTS’s V and Jungkook Unable to Settle Defamation Lawsuit with Sojang Operator

The song "Shine On Me" will also serve as the ending theme for the local Japanese drama Even Shrimp Want to Catch a Sea Bream (海老だって鯛が釣りたい). This move highlights just how much the group is gaining traction and popularity in Japan.

ENHYPEN Singapore Announcement

ENHYPEN Group Image

Subscribe
Notify of
guest


0 Comments
Most Voted
Newest Oldest
Inline Feedbacks
View all comments